Zobrazeno 1 - 10
of 20
pro vyhledávání: '"J P, Struewing"'
Autor:
J. P. Struewing, Christopher I. Amos
Publikováno v:
Cancer. 71:566-572
Aside from age, family history is the strongest predictor of ovarian cancer risk. Genetic components of risk for ovarian cancer have been evaluated by a number of designs, including case-control studies of family history and other risk factors, segre
Autor:
Barbara Marinelli, Mohammad Hedayati, Lawrence Grossman, Donato Calista, M. T. Landi, P Minghetti, T Tseng, Benedetta Albetti, Giorgio Landi, Andrea A. Baccarelli, J P Struewing
Publikováno v:
British Journal of Cancer
We recently reported an association between low DNA repair capacity, measured through the host-cell reactivation assay, and melanoma risk in subjects with dysplastic naevi or low tanning ability. We investigated the genetic basis for these findings b
Autor:
Eitan Friedman, R. Gershoni, J. P. Struewing, Angela Chetrit, Flora Lubin, Rizel S, Baruch Modan, Tamar Peretz, G Hirsh-Yechezkel
Publikováno v:
Gynecologic Oncology. 89:494-498
Objective The objective was to evaluate the prevalence of BRCA1/2 mutations in selected categories of ovarian cancer patients in Israel. Methods Blood samples and specimens of ovarian tumors were obtained in the course of a national case control stud
Publikováno v:
British Journal of Cancer
One of the most common melanoma-related CDKN2A mutations reported in North America is the V126D mutation. We examined nine markers surrounding CDKN2A in three American and four Canadian families carrying the V126D mutation. All seven families had a h
Autor:
Chen-Yang Shen, Show Lin Yang, Bolot Kalmyrzaev, Michael F. Press, Dong Young Noh, Leslie Bernstein, Elaine A. Ostrander, Giske Ursin, Sei Hyun Ahn, J. P. Struewing, Annika Lindblom, Brian E. Henderson, Eric Karlins, Douglas F. Easton, Robert Luben, Kerstin B. Meyer, Radhika Prathalingam, Kathleen E. Malone, Carlos Caldas, Christopher A. Haiman, Ana-Teresa Maia, Miriam S. Udler, Ed Dicks, Radka Platte, Keun-Young Yoo, Anna H. Wu, Alison M. Dunning, Paul D.P. Pharoah, David R. Doody, Bruce A.J. Ponder, Loic Le Marchand, Catherine S. Healey, Chia-Ni Hsiung, Laurence K. Kolonel, Sara Margolin, Erika M. Kwon, Stewart McArthur, Helen I. Field, Jinghui Zhang, Andrew E. Teschendorff, Jonathan Tyrer, Daehee Kang, Melanie Maranian, Shahana Ahmed
Publikováno v:
Human Molecular Genetics
Human Molecular Genetics; Vol 19
Human Molecular Genetics; Vol 19
Recent genome-wide association studies have identified a breast cancer susceptibility locus on 16q12 with an unknown biological basis. We used a set of single nucleotide polymorphism (SNP) markers to generate a fine-scale map and narrowed the region
Autor:
Dale L. Preston, Alice J. Sigurdson, Laura Bowen, Michael Hauptmann, Parveen Bhatti, Bruce H. Alexander, J. P. Struewing, Marvin Rosenstein, Michele M. Doody, Robert M. Weinstock, Steven L. Simon, Preetha Rajaraman, Marilyn Stovall, Martha S. Linet
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 16(10)
Background: Although genes involved in apoptosis pathways and DNA repair pathways are both essential for maintaining genomic integrity, genetic variants in DNA repair have been thought to increase susceptibility to radiation carcinogenesis, but simil
Autor:
T Wagner, Kenneth Offit, Katherine L. Nathanson, Peter Devilee, Janet E. Olson, Ilyushik E, Lenka Foretova, Jacek Gronwald, Pascaline Berthet, Muhammad Usman Rashid, Isabelle Coupier, Noralane M. Lindor, T A Sellers, Alfons Meindl, Dieter Schaefer, Shirley Hodgson, Beatrix Versmold, Olufunmilayo I. Olopade, Susan M. Domchek, Christoph Engel, Olga M. Sinilnikova, Vernon S. Pankratz, Gail E. Tomlinson, David J. Hughes, Amanda B. Spurdle, Horst J, Jakub Lubiński, Maaike P.G. Vreeswijk, Gordon Glendon, Robert A. Vierkant, Francine Durocher, Frédéric Guénard, Henry T. Lynch, Douglas F. Easton, Mary B. Daly, Susan Peock, Åke Borg, Jacques Simard, Heli Nevanlinna, Georgia Chenevix-Trench, Irene L. Andrulis, M. Cook, Caroline Baynes, Steven A. Narod, Judy Garber, Mark H. Greene, J. N. Weitzel, Patrick J. Morrison, Anna Jakubowska, Johanna Tommiska, Kristiina Aittomäki, Hans F. A. Vasen, Claudine Isaacs, Csilla Szabo, Dominique Stoppa-Lyonnet, Fergus J. Couch, Michal Zikan, Backenhorn K, Christian Sutter, Diana Torres, Antonis C. Antoniou, Ute Hamann, Andrew K. Godwin, kConFab, Rita K. Schmutzler, Tomas Kirchhoff, Susan L. Neuhausen, Zachary S. Fredericksen, Agnès Hardouin, Timothy R. Rebbeck, J. P. Struewing, Mary Porteous
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 16(7)
The AURKA oncogene is associated with abnormal chromosome segregation and aneuploidy and predisposition to cancer. Amplification of AURKA has been detected at higher frequency in tumors from BRCA1 and BRCA2 mutation carriers than in sporadic breast t
Publikováno v:
Epidemiology (Cambridge, Mass.). 14(6)
SUMMARY BACKGROUND Over-expression of the human epidermal growth factor receptor 2 (Her2) protooncogene is associated with poor prognosis among female patients with breast cancer. A polymorphism in the HER2 gene (I655V) has been associated with an el
Autor:
M. Altaras, J. P. Struewing, Angela Chetrit, Y. Fishler, Giulia Barda, Baruch Modan, Flora Lubin, Siegal Sadetzki, Hanoch Levavi, Joseph Menczer
Publikováno v:
Gynecologic oncology. 88(1)
Objective. The aim of the present study was to compare demographic and clinical characteristics of primary peritoneal carcinoma (PPC) to ovarian carcinoma (OvC) with regard to BRCA mutation frequencies. Methods. Incident cases of histologically confi
Autor:
W W, Wang, A B, Spurdle, P, Kolachana, B, Bove, B, Modan, S M, Ebbers, G, Suthers, M A, Tucker, D J, Kaufman, M M, Doody, R E, Tarone, M, Daly, H, Levavi, H, Pierce, A, Chetrit, G H, Yechezkel, G, Chenevix-Trench, K, Offit, A K, Godwin, J P, Struewing
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 10(9)
RAD51 colocalizes with both BRCA1 and BRCA2, and genetic variants in RAD51 would be candidate BRCA1/2 modifiers. We searched for RAD51 polymorphisms by sequencing 20 individuals. We compared the polymorphism allele frequencies between female BRCA1/2